80
Participants
Start Date
July 1, 2017
Primary Completion Date
December 31, 2024
Study Completion Date
June 1, 2025
Darbepoetin Alfa
Darbepoetin alfa (Aranesp, Amgen) 2 doses of 10 microgram/kg i.v.
Saline
The placebo will consist of saline, containing 9.0 g of salt per liter (0.90%) i.v.
RECRUITING
Wilhelmina Childrens Hostpital/University Medical Center Utrecht, Utrecht
Alberta Children's Hospital
OTHER
The Hospital for Sick Children
OTHER
UMC Utrecht
OTHER